Coeptis Therapeutics Warrants
COEPW
COEPW was delisted on the 24th of April, 2026.
13 hedge funds and large institutions have $21.4K invested in Coeptis Therapeutics Warrants in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.
1.97% less ownership
Funds ownership: 4.47% → 2.5% (-2%)
22% less capital invested
Capital invested by funds: $27.4K → $21.4K (-$6.05K)
24% less funds holding
Funds holding: 17 → 13 (-4)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
+$1.47K |
| 2 |
CS
Clear Street
New York
|
+$590 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$15 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MC
Meteora Capital
Boca Raton,
Florida
|
-$14K |
| 2 |
Walleye Capital
New York
|
-$1.64K |
| 3 |
ICM
Ionic Capital Management
New York
|
-$1.4K |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$418 |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$15 |
COEPW Hedge Fund Activity: Q4 2024 in Review
13 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q4 2024, worth a combined $21.4K — down 22% from $27.4K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of COEPW and 0 opened new positions — a net loss of 4 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was Walleye Trading, adding an estimated $1.47K. The largest seller was Meteora Capital, cutting an estimated $14K.
- 13 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q4 2024, down from 17 in Q3 2024.
- Funds reported $21.4K of Coeptis Therapeutics Warrants stock for Q4 2024, down 22% quarter-over-quarter.
- 0 funds opened new Coeptis Therapeutics Warrants positions in Q4 2024 and 4 closed out, a net change of -4 holders.
- The largest Coeptis Therapeutics Warrants buyer in Q4 2024 was Walleye Trading, an estimated $1.47K added.
- The largest Coeptis Therapeutics Warrants seller in Q4 2024 was Meteora Capital, an estimated $14K sold.
Based on aggregated 13F filings for Q4 2024.